Literature DB >> 33090375

Origin and Pathogenic Mechanisms of Uterine Adenomyosis: What Is Known So Far.

Christina Anna Stratopoulou1, Jacques Donnez2, Marie-Madeleine Dolmans3,4.   

Abstract

Uterine adenomyosis is a benign disease, commonly encountered in reproductive-age women and responsible for chronic pelvic pain, abnormal uterine bleeding, and infertility. Although the exact origin and pathogenic mechanisms involved in adenomyosis still need to be elucidated, significant progress has been made over recent years. Ever since the theory of endometrium invaginating the myometrium via a traumatized interface was first proposed, numerous molecular mechanisms have been reported to participate in this process. At the same time, an alternative theory has suggested de novo development of adenomyotic lesions from metaplasia of Müllerian remnants or adult stem cells. Hence, our understanding of the pathogenesis of adenomyosis has been greatly enhanced and is anticipated to pave the way for development of an effective and safe treatment. The goal of this review is to analyze current knowledge on the origin and pathogenic mechanisms of adenomyosis, ranging from the most widely accepted theories to newly reported data.
© 2020. Society for Reproductive Investigation.

Entities:  

Keywords:  Adenomyosis; Disease mechanisms; Invagination; Metaplasia; Pathogenesis

Mesh:

Year:  2020        PMID: 33090375     DOI: 10.1007/s43032-020-00361-w

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  74 in total

Review 1.  Uterine Cystic Adenomyosis: A Disease of Younger Women.

Authors:  Ivo Brosens; Stephan Gordts; Marwan Habiba; Giuseppe Benagiano
Journal:  J Pediatr Adolesc Gynecol       Date:  2014-05-28       Impact factor: 1.814

2.  Adenomyosis: symptoms, histology, and pregnancy terminations.

Authors:  M Levgur; M A Abadi; A Tucker
Journal:  Obstet Gynecol       Date:  2000-05       Impact factor: 7.661

3.  The elusive adenomyosis of the uterus--revisited.

Authors:  C C Bird; T W McElin; P Manalo-Estrella
Journal:  Am J Obstet Gynecol       Date:  1972-03       Impact factor: 8.661

4.  Introduction: Uterine adenomyosis, another enigmatic disease of our time.

Authors:  Jacques Donnez; Olivier Donnez; Marie-Madeleine Dolmans
Journal:  Fertil Steril       Date:  2018-03-08       Impact factor: 7.329

Review 5.  Adenomyosis: epidemiological factors.

Authors:  Paolo Vercellini; Paola Viganò; Edgar Somigliana; Raffaella Daguati; Annalisa Abbiati; Luigi Fedele
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2006-03-24       Impact factor: 5.237

Review 6.  Pathogenesis of uterine adenomyosis: invagination or metaplasia?

Authors:  Javier García-Solares; Jacques Donnez; Olivier Donnez; Marie-Madeleine Dolmans
Journal:  Fertil Steril       Date:  2018-03       Impact factor: 7.329

7.  Determinants of adenomyosis in women who underwent hysterectomy for benign gynecological conditions: results from a prospective multicentric study in Italy.

Authors:  F Parazzini; V Mais; S Cipriani; M Busacca; P Venturini
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2009-02-18       Impact factor: 2.435

8.  Diagnosing adenomyosis: an integrated clinical and imaging approach.

Authors:  Charles Chapron; Silvia Vannuccini; Pietro Santulli; Mauricio S Abrão; Francisco Carmona; Ian S Fraser; Stephan Gordts; Sun-Wei Guo; Pierre-Alexandre Just; Jean-Christophe Noël; George Pistofidis; Thierry Van den Bosch; Felice Petraglia
Journal:  Hum Reprod Update       Date:  2020-02-25       Impact factor: 15.610

9.  How common is adenomyosis? A prospective study of prevalence using transvaginal ultrasound in a gynaecology clinic.

Authors:  J Naftalin; W Hoo; K Pateman; D Mavrelos; T Holland; D Jurkovic
Journal:  Hum Reprod       Date:  2012-09-20       Impact factor: 6.918

10.  Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease.

Authors:  J M Puente; A Fabris; J Patel; A Patel; M Cerrillo; A Requena; J A Garcia-Velasco
Journal:  Reprod Biol Endocrinol       Date:  2016-09-20       Impact factor: 5.211

View more
  11 in total

1.  RNA-seq reveals co-dysregulated circular RNAs in the adenomyosis eutopic endometrium and endometrial-myometrial interface.

Authors:  Zhengchen Guo; Hua Duan; Sha Wang; Sirui Wang; Qi Lin; Yazhu Li
Journal:  BMC Womens Health       Date:  2022-07-15       Impact factor: 2.742

2.  Upregulated Talin1 synergistically boosts β-estradiol-induced proliferation and pro-angiogenesis of eutopic and ectopic endometrial stromal cells in adenomyosis.

Authors:  Yi-Yi Wang; Hua Duan; Sha Wang; Yong-Jun Quan; Jun-Hua Huang; Zheng-Chen Guo
Journal:  Reprod Biol Endocrinol       Date:  2021-05-14       Impact factor: 5.211

3.  Mode Switch of Ca2 + Oscillation-Mediated Uterine Peristalsis and Associated Embryo Implantation Impairments in Mouse Adenomyosis.

Authors:  Mingzi Qu; Ping Lu; Karl Bellve; Lawrence M Lifshitz; Ronghua ZhuGe
Journal:  Front Physiol       Date:  2021-11-04       Impact factor: 4.755

Review 4.  Ectopic Endometrium: The Pathologist's Perspective.

Authors:  Alessandra Camboni; Etienne Marbaix
Journal:  Int J Mol Sci       Date:  2021-10-11       Impact factor: 5.923

Review 5.  Progesterone Actions and Resistance in Gynecological Disorders.

Authors:  James A MacLean; Kanako Hayashi
Journal:  Cells       Date:  2022-02-13       Impact factor: 6.600

6.  Establishment of Adenomyosis Organoids as a Preclinical Model to Study Infertility.

Authors:  Elena Juárez-Barber; Emilio Francés-Herrero; Ana Corachán; Carmina Vidal; Juan Giles; Pilar Alamá; Amparo Faus; Antonio Pellicer; Irene Cervelló; Hortensia Ferrero
Journal:  J Pers Med       Date:  2022-02-04

Review 7.  The Role of mTOR and eIF Signaling in Benign Endometrial Diseases.

Authors:  Tatiana S Driva; Christoph Schatz; Monika Sobočan; Johannes Haybaeck
Journal:  Int J Mol Sci       Date:  2022-03-22       Impact factor: 5.923

8.  Reproductive Outcomes of In Vitro Fertilization and Fresh Embryo Transfer in Infertile Women With Adenomyosis: A Retrospective Cohort Study.

Authors:  Tingting Liang; Wen Zhang; Ningning Pan; Bing Han; Rong Li; Caihong Ma
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-29       Impact factor: 6.055

9.  Uterine Adenomyosis Treated by Linzagolix, an Oral Gonadotropin-Releasing Hormone Receptor Antagonist: A Pilot Study with a New 'Hit Hard First and then Maintain' Regimen of Administration.

Authors:  Jacques Donnez; Olivier Donnez; Jean Tourniaire; Michel Brethous; Elke Bestel; Elizabeth Garner; Sébastien Charpentier; Andrew Humberstone; Ernest Loumaye
Journal:  J Clin Med       Date:  2021-12-10       Impact factor: 4.241

Review 10.  Unveiling the Pathogenesis of Adenomyosis through Animal Models.

Authors:  Xi Wang; Giuseppe Benagiano; Xishi Liu; Sun-Wei Guo
Journal:  J Clin Med       Date:  2022-03-21       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.